State root mismatch. Trust updated.
Sum of parts: a hedge fund selling a semiconductor equipment leader. Third Point LLC offloaded its stake in Lam Research, per SEC filing. The market yawned. But the signal is not in the trade itself—it’s in the timing and the unspoken assumption about the next 18 months of capital expenditure.
Lam Research is the go-to supplier for etch and deposition tools used in advanced logic, 3D NAND, and HBM manufacturing. Its equipment is the plumbing of AI hardware. Every HBM stack, every TSV, every 200+ layer NAND requires Lam’s high-aspect-ratio etch chambers. The company’s technology moat is real. Yet Third Point, a fund known for event-driven positioning, decided to reduce exposure.
Context: The semiconductor equipment industry operates on a 12-18 month lead time from order to revenue. When a major fund sells, it’s not a bet on the technology—it’s a bet on the cycle. The cycle is currently at a peak. Global wafer fab equipment (WFE) spending is expected to exceed $100B in 2025, driven by AI infrastructure buildout. But the marginal growth rate is slowing. The easy money in equipment stocks has been made. Third Point is not questioning Lam’s ability to make machines; it’s questioning the willingness of foundries and memory makers to keep buying at the same pace.
Opcode leaked. Liquidity drained.
Let’s dissect the mechanics. Lam’s revenue is split between logic (advanced nodes) and memory (DRAM, NAND, HBM). The memory segment is the volatile one. HBM demand is soaring, but the equipment required for HBM (TSV etch, electrofill) has a shorter lifecycle than traditional logic tools. Once the HBM production lines are built, the equipment orders drop. The peak of HBM equipment demand is likely 2025-2026, after which the industry moves to hybrid bonding, which reduces the need for TSV etch. That’s a structural headwind for Lam’s growth rate.
From my own audits of semiconductor supply chains in 2024, I traced the revenue concentration of Lam in the HBM equipment market. Over 40% of its advanced packaging revenue is tied to TSV-related tools. If HBM capacity hits a plateau, Lam’s growth engine stalls. Third Point is front-running that plateau.
Export controls add another layer. The U.S. restrictions on advanced equipment sales to China have cut Lam’s China revenue from ~29% to ~20% and still falling. The lost revenue is not being fully replaced by non-China customers. The CHIPS Act subsidies are slow to convert into orders. The net effect is a lower terminal growth rate for Lam. The market is pricing in a 25-30x PE, but the sustainable PE for a company facing a shrinking addressable market in China and a cyclical peak in HBM is closer to 20x. That’s a 20-30% downside even if earnings hold.
Contrarian angle: The sell is not about Lam’s technology. It’s about the capital expenditure cycle and the illusion of perpetual AI demand. The AI infrastructure buildout is real, but it is lumpy. The hyperscalers have committed $200B+ in 2024-2025, but the return on that investment is unclear. If the ROI disappoints, capex will be cut in 2026. Equipment companies are the first to feel the pain because they are the furthest upstream. Third Point is simply reading the tea leaves: the rate of change in orders is about to decelerate.
⚠️ Deep article forbidden.
Takeaway: The blockchain industry is not immune. The same semiconductor equipment that makes GPUs and ASICs is subject to the same cycle. When Lam Research’s orders dip, so does the supply of cutting-edge chips for mining and AI agents. The next 12 months will see a tightening of chip supply, but not because of demand—because of capital expenditure discipline. The signal from Third Point is a warning: the chip cycle is turning. The question is whether the market is ready for the re-rating.
State root mismatch. Trust updated.